All instruments
Glenmark Pharmaceuticals Limited
- Stock
- GLENMARK
- NSE
- ₹2,226.70−1.06%
- Delayed close, 16 Oct
Details
- INE935A01035
- Healthcare
- Pharmaceuticals
- Face value ₹1
- Market cap ₹62,843 Cr
Paid for 18 years without a break
Dividend per share by FY
Split-adjusted · FY27 to date · last 7 of 21 years · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY02 | ₹4.00 |
| FY07 | ₹0.40 |
| FY08 | ₹0.70 |
| FY10 | ₹0.40 |
| FY11 | ₹0.40 |
| FY12 | ₹0.40 |
| FY13 | ₹2.00 |
| FY14 | ₹2.00 |
| FY15 | ₹2.00 |
| FY16 | ₹2.00 |
| FY17 | ₹2.00 |
| FY18 | ₹2.00 |
| FY19 | ₹2.00 |
| FY20 | ₹2.00 |
| FY21 | ₹2.50 |
| FY22 | ₹2.50 |
| FY23 | ₹2.50 |
| FY24 | ₹2.50 |
| FY25 | ₹2.50 |
| FY26 | ₹5.00 |
| FY27 | ₹2.50 |
TTM payout
₹2.50
1 payout in 12 months
Yield
0.11%
Dividend yield · trailing 12 months
52-wk closing range ₹1,810.40 – ₹2,515.00
Yield and payout totals recalculated 18 Oct 2026.
Recent payouts
· 22 on record since FY02| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 31 Aug 2026 | Final | same day | ₹2.50 |
| 03 Oct 2025 | Interim | same day | ₹2.50 |
| 15 Sep 2025 | Final | same day | ₹2.50 |
| 13 Sep 2024 | Final | — | ₹2.50 |
| 18 Sep 2023 | Final | — | ₹2.50 |
Income calculator
₹110
Expected income per year, before tax, at the current 0.11% yield
≈ 44 shares at ₹2,226.70, using ₹97,975 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.